WallStreetZenWallStreetZen

NYSE: CAH
Cardinal Health Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for CAH

Based on 9 analysts offering 12 month price targets for Cardinal Health Inc.
Min Forecast
$58.00-12.4%
Avg Forecast
$69.22+4.55%
Max Forecast
$78.00+17.81%

Should I buy or sell CAH stock?

Based on 9 analysts offering ratings for Cardinal Health Inc.
Buy
Strong Buy
3 analysts 33.33%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CAH stock forecasts and price targets.

CAH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
UBS
Bottom 27%
27
Strong BuyMaintains$78.00+17.81%2022-08-29
Morgan Stanley
Top 4%
97
Strong BuyMaintains$76.00+14.79%2022-08-22
Cowen & Co.
Bottom 33%
33
HoldMaintains$72.00+8.74%2022-08-16
Credit Suisse
Top 5%
96
HoldMaintains$64.00-3.34%2022-08-12
Baird
Top 40%
61
HoldMaintains$73.00+10.26%2022-08-12
Morgan Stanley
Top 2%
99
Strong BuyMaintains$70.00+5.72%2022-07-14
Barclays
Bottom 22%
22
HoldDowngrades$64.00-3.34%2022-05-26
Evercore ISI Group
Bottom 13%
13
BuyUpgrades$68.00+2.70%2022-05-18
Credit Suisse
Bottom 3%
3
HoldMaintains$58.00-12.40%2022-02-04
Anonymous
Morgan Stanley
HoldMaintains$54.00-18.44%2021-12-17

1 of 1

Forecast return on equity

Is CAH forecast to generate an efficient return?
Company
-231%
Industry
176.02%
Market
108.8%
CAH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CAH forecast to generate an efficient return on assets?
Company
3.73%
Industry
5.57%
CAH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CAH earnings per share forecast

What is CAH's earnings per share in the next 2 years based on estimates from 7 analysts?
Avg 1 year Forecast
$5.34
Avg 2 year Forecast
$6.01

CAH revenue forecast

What is CAH's revenue in the next 2 years based on estimates from 5 analysts?
Avg 1 year Forecast
$192.6B+6.22%
Avg 2 year Forecast
$202.5B+11.67%
CAH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CAH revenue growth forecast

How is CAH forecast to perform vs Medical Distribution companies and vs the US market?
Company
5.67%
Industry
3.65%
Market
8.28%
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CAH vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
CAH$66.21$69.22+4.55%Buy
HSIC$66.12$85.11+28.72%Hold
ABC$135.44$168.20+24.19%Buy
PBH$48.72$64.33+32.05%Buy
PDCO$24.71$35.75+44.68%Buy

Cardinal Health Stock Forecast FAQ

Is Cardinal Health Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: CAH) stock is to Buy CAH stock.

Out of 9 analysts, 3 (33.33%) are recommending CAH as a Strong Buy, 1 (11.11%) are recommending CAH as a Buy, 5 (55.56%) are recommending CAH as a Hold, 0 (0%) are recommending CAH as a Sell, and 0 (0%) are recommending CAH as a Strong Sell.

If you're new to stock investing, here's how to buy Cardinal Health stock.

What is CAH's earnings growth forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 33.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.65%.

Cardinal Health's earnings in 2022 is -$933,000,000.On average, 7 Wall Street analysts forecast CAH's earnings for 2023 to be $1,455,216,024, with the lowest CAH earnings forecast at $1,408,888,922, and the highest CAH earnings forecast at $1,558,770,722.

In 2024, CAH is forecast to generate $1,637,799,308 in earnings, with the lowest earnings forecast at $1,550,595,351 and the highest earnings forecast at $1,722,278,140.

What is CAH's revenue growth forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's forecast annual revenue growth rate of 5.67% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 3.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.28%.

Cardinal Health's revenue in 2022 is $181,364,000,000.On average, 5 Wall Street analysts forecast CAH's revenue for 2023 to be $52,495,954,453,423, with the lowest CAH revenue forecast at $50,957,631,969,088, and the highest CAH revenue forecast at $54,540,134,008,705.

In 2024, CAH is forecast to generate $55,192,611,996,904 in revenue, with the lowest revenue forecast at $52,951,877,448,840 and the highest revenue forecast at $57,597,613,727,839.

What is CAH's forecast return on assets (ROA) for 2023-2024?

(NYSE: CAH) forecast ROA is 3.73%, which is lower than the forecast US Medical Distribution industry average of 5.57%.

What is CAH's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CAH price target, the average CAH price target is $69.22, with the highest CAH stock price forecast at $78.00 and the lowest CAH stock price forecast at $58.00.

On average, Wall Street analysts predict that Cardinal Health's share price could reach $69.22 by Aug 29, 2023. The average Cardinal Health stock price prediction forecasts a potential upside of 4.55% from the current CAH share price of $66.21.

What is CAH's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's current Earnings Per Share (EPS) is -$3.35. On average, analysts forecast that CAH's EPS will be $5.34 for 2023, with the lowest EPS forecast at $5.17, and the highest EPS forecast at $5.72. In 2024, CAH's EPS is forecast to hit $6.01 (min: $5.69, max: $6.32).

What is CAH's forecast return on equity (ROE) for 2023-2024?

(NYSE: CAH) forecast ROE is -231%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.